Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project
Qing Yang, Dongdong Sun, Chongzhe Pei, et al.
European Heart Journal (2021) Vol. 42, Iss. 33, pp. 3175-3186
Open Access | Times Cited: 25

Showing 25 citing articles:

Aging and Cardiovascular Disease: Current Status and Challenges
Mengge Zhou, Guanqi Zhao, Yuhong Zeng, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 20
Combined effect of inflammation and malnutrition for long-term prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study
Yang Yuxiu, Xiaoteng Ma, Fei Gao, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Association of LDL-C with stroke and all-cause mortality in hypertensive patients with high risk of ASCVD
Shuang Guo, Chi Wang, Taoyu Hu, et al.
Clinical Hypertension (2025) Vol. 31
Open Access
Low LDL-cholesterol drives the risk of bleeding in patients treated with aspirin: A 15-year study in a real-world large population
Valentina Trimarco, Raffaele Izzo, Daniela Pacella, et al.
Pharmacological Research (2025), pp. 107688-107688
Open Access
Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients With Percutaneous Coronary Intervention and High Bleeding Risk: Rationale and Protocol for a Multi-Center Cohort Study
Junyan Zhang, Zhongxiu Chen, Hua Wang, et al.
Cardiology Discovery (2024) Vol. 4, Iss. 3, pp. 213-220
Open Access | Times Cited: 3
The interdependence of mid-trimester blood pressure and glucose levels in shaping fetal growth and neonatal outcomes: implications for risk–benefit assessment and co-management
Lijuan Lv, Jingbo Yang, Linjie Li, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA
Aichun Cheng, Jing Xue, Anxin Wang, et al.
JAMA Neurology (2024) Vol. 81, Iss. 4, pp. 354-354
Closed Access | Times Cited: 2
Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants
Yuanyuan Liu, Linjie Li, Jingge Li, et al.
Clinical and Applied Thrombosis/Hemostasis (2024) Vol. 30
Open Access | Times Cited: 2
Low HDL Cholesterol Is Associated with Reduced Bleeding Risk in Patients Who Underwent PCI: Findings from the PRACTICE Study
Ying‐Ying Zheng, Tingting Wu, Xian‐Geng Hou, et al.
Thrombosis and Haemostasis (2023) Vol. 125, Iss. 02, pp. 178-187
Closed Access | Times Cited: 4
Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy
Bernadeta Chyrchel, Olga Kruszelnicka, Ewa Wieczorek‐Surdacka, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4530-4530
Open Access | Times Cited: 3
Antithrombotic therapy and bleeding risk in the era of aggressive lipid-lowering: current evidence, clinical implications, and future perspectives
Xin Zhou, Ziping Li, Hangkuan Liu, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 6, pp. 645-652
Open Access | Times Cited: 2
Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
Jiawen Li, Yulong Li, Pei Zhu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107666-107666
Open Access | Times Cited: 2
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore
Xin Qin Soh, Doreen Su‐Yin Tan, Eric Chun Yong Chan
Cardiovascular Drugs and Therapy (2022) Vol. 37, Iss. 5, pp. 917-925
Closed Access | Times Cited: 4
Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 32, pp. 3023-3026
Open Access | Times Cited: 2
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Diana A. Gorog, Eliano Pio Navarese, Felicita Andreotti
European Heart Journal (2021) Vol. 42, Iss. 33, pp. 3187-3189
Closed Access | Times Cited: 4
Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients Presenting with Increased Platelet Count
Y. Zhang, Yongchen Hao, Jun Liu, et al.
Research Square (Research Square) (2024)
Open Access
Low Remnant Cholesterol and In‐Hospital Bleeding Risk After Ischemic Stroke or Transient Ischemic Attack
Zhiyuan Wu, H Zhang, Yi Xu, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 14
Open Access
Chitosan‐Based Hemostatic Pad Reduced Vascular Complications After Transradial Coronary Intervention in Uncontrolled Hypertensive Patients: Application of Chitosan‐Based Hemostatic Pad on CAG or PCI
Qian Lu, Mingqiang Cao, Zexiong Feng, et al.
Journal of Interventional Cardiology (2024) Vol. 2024, Iss. 1
Open Access
The Impact of Gender on In-Hospital Outcome after Elective Percutaneous Coronary Intervention: A Comparative Single Center Audit
Abdulhafeedh Al-Habeet, Taha Almaimony
Journal of Cardiology Research Review & Reports (2023), pp. 1-6
Open Access | Times Cited: 1
Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia
Yicong Ye, Yongchen Hao, Xiliang Zhao, et al.
Thrombosis and Haemostasis (2023)
Closed Access | Times Cited: 1
Low-Density Lipoprotein Cholesterol and Mortality Risk in Elderly Patients Undergoing Valve Replacement Surgery: A Propensity Score Matching Analysis
Han-biao Li, Bingqi Fu, Tong Tan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 1
Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment
Filippo Crea
European Heart Journal (2021) Vol. 42, Iss. 33, pp. 3109-3113
Open Access | Times Cited: 1
Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer
Huixia Lu, Hong Hu, Zhihong Yang, et al.
Medicine (2023) Vol. 102, Iss. 17, pp. e33515-e33515
Open Access
Thrombotic and bleeding complications during antithrombotic treatment: the need for new therapeutic targets
Filippo Crea
European Heart Journal (2023) Vol. 44, Iss. 20, pp. 1767-1770
Open Access
Non-high-density lipoprotein cholesterol levels as a risk factor for short-term mortality in elderly Chinese: a large-scale, population-based cohort study
Weiwei Xiao, Shiqi Liu, Zheng Huang, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e078216-e078216
Open Access
Page 1

Scroll to top